Aging and Lung Cancer: The Silent Crisis in Treatment Decisions
The SIOG 2025 Roundtable Discussion, Perspectives on Complexities in Treatment Selection for Older Adults with Lung Cancer, shed light on a critical yet often overlooked challenge in oncology. Led by Fabio Gomes (Manchester), this gathering of pulmonologists, oncologists, geriatricians, and supportive care specialists delved into the intricate decisions surrounding geriatric lung cancer care. But here's where it gets controversial: How often do we prioritize tumor-centric treatments over the holistic needs of older patients?
A Real-Life Case Unveils Hidden Complexities
The discussion centered on a real clinical case of an older adult newly diagnosed with lung cancer. This case wasn't just about the cancer—it exposed the diagnostic uncertainties, the burden of comorbidities, functional limitations, and competing health priorities that guidelines rarely address. Early symptoms, diagnostic findings, and initial management steps were presented, setting the stage for a deeper exploration.
When Specialists Disagree: The Unspoken Divide
Under the guidance of Prof. Lore Decoster, panelists dissected the case from pulmonology and geriatric oncology perspectives. The conversation revealed a striking reality: imaging choices, biopsy decisions, and risk assessments can vary wildly depending on the specialist's viewpoint. And this is the part most people miss: Critical details, especially functional and psychosocial factors, often go unaddressed when geriatric expertise is absent from multidisciplinary discussions.
Toxicity, Treatment Failures, and the Cost of Oversight
The patient’s treatment journey became a cautionary tale. Systemic therapy was initiated without a geriatric assessment, leading to severe toxicity that derailed the plan. This sparked a broader debate: Could frailty indicators, polypharmacy risks, cognitive issues, or functional decline have been anticipated and mitigated with a more comprehensive approach? Panelists agreed that many complications are predictable—and preventable—when geriatric principles are integrated into decision-making.
Geriatric Assessment: Not an Extra Step, but a Lifeline
The session shifted to actionable solutions. Siri Rostoft (Oslo) and Theodora Karnakis (São Paulo) demonstrated how geriatric assessments can be seamlessly woven into lung cancer care. Even brief screening tools can identify vulnerabilities that shape dosing, treatment intensity, and supportive care needs. They stressed that geriatric assessment isn’t just an add-on—it’s a safety net that fosters individualized, realistic treatment plans.
Global Echoes of a Shared Struggle
Audience members from diverse regions shared their experiences, recounting cases where the absence of geriatric assessment led to overly aggressive therapies, avoidable toxicities, or missed opportunities for supportive care. The discussion underscored a universal challenge: treating older adults with lung cancer requires navigating overlapping medical, functional, and social complexities.
Closing Thoughts: Bridging the Gap for Better Care
In his closing remarks, Fabio Gomes reiterated the roundtable’s core message: improving outcomes for older adults with lung cancer demands coordinated, multidisciplinary decision-making rooted in geriatric principles. Diagnostics, treatment planning, and toxicity management must consider the whole patient, not just the tumor. Integrating geriatric assessments, embedding structured pathways, and embracing a more measured approach are essential steps forward.
This roundtable left no doubt: while complexity is inevitable, collaborative, thoughtful care across disciplines can revolutionize the treatment experience for older adults with lung cancer. But here’s a question to ponder: Are we doing enough to prioritize geriatric insights in oncology, or is there still a gap that needs bridging?
For more insights, click here: https://siog2025.abstractserver.com/program/#/details/sessions/59
